Center for Evolution and Medicine,
School of Life Sciences,
Center for Evolution and Medicine, School of Life Sciences
Silvie Huijben is an evolutionary biologist with a keen interest in the arms-race between us humans and the organisms we aim to control. Her work focuses on the evolution of drug resistance in malaria parasites and insecticide resistance in mosquitoes. Dr. Huijben aims to use empirical research on the evolutionary ecology of mosquitoes and parasites to answer the following key question: how can we design better resistance management strategies? Silvie Huijben started her PhD in evolutionary biology and infectious diseases at the University of Edinburgh (UK) and later moved to the Center for Infectious Disease Dynamics (CIDD) at the Pennsylvania State University (USA) under supervision of Dr. Andrew Read. She received her PhD degree from the University of Edinburgh in 2010 and continued with a post-doctoral position at CIDD. She obtained a Science in Society – Branco Weiss Fellowship and a Marie Curie Incoming International Fellowship and for a post-doctoral position at the Barcelona Institute for Global Health (ISglobal, Spain) in 2013. In 2018 she joined the Center for Evolution and Medicine at Arizona State University as Assistant Professor where she received an NSF-CAREER award in 2021 to work on understanding the selective forces acting on insecticide resistant mosquitoes.
The impact of within-host ecology on the fitness of a drug-resistant parasite.
Evolution, medicine, and public health , 2018 | Pubmed ID: 30087774
Escalation of Pyrethroid Resistance in the Malaria Vector Anopheles funestus Induces a Loss of Efficacy of Piperonyl Butoxide-Based Insecticide-Treated Nets in Mozambique.
The Journal of infectious diseases 07, 2019 | Pubmed ID: 30923819
Phenotypic insecticide resistance in arbovirus mosquito vectors in Catalonia and its capital Barcelona (Spain).
PloS one , 2019 | Pubmed ID: 31276554
Genetic affinities of an eradicated European strain.
Microbial genomics 09, 2019 | Pubmed ID: 31454309
Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by Next Generation Sequencing of Plasmodium falciparum.
Malaria journal Oct, 2019 | Pubmed ID: 31623623
Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
The Journal of infectious diseases 01, 2020 | Pubmed ID: 31677349
Plasmodium vivax Malaria Viewed through the Lens of an Eradicated European Strain.
Molecular biology and evolution 03, 2020 | Pubmed ID: 31697387
Taking the 'I' out of LLINs: using insecticides in vector control tools other than long-lasting nets to fight malaria.
Malaria journal Feb, 2020 | Pubmed ID: 32059675
The need for practical insecticide-resistance guidelines to effectively inform mosquito-borne disease control programs.
eLife 08, 2021 | Pubmed ID: 34355693
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。